Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesDo Patients Die from Rashes from Epidermal Growth Factor Receptor Inhibitors? A Systematic Review to Help Counsel Patients About Holding Therapy
The Oncologist, 12/03/08
Jatoi A et al. - Although authors cannot conclude that a rash-related death from this class of agents can never occur, this systematic review provides evidence-based guidance on how best to counsel cancer patients who develop a rash from an epidermal growth factor receptor inhibitor. It suggests that quality of life issues should remain at the forefront as cancer patients and health care providers make decisions about holding cancer therapy.
Related Articles
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09
Relevance Score: 90%
Severe pruritic rash, fever, and malaise
The Clinical Advisor, 11/10/09
Relevance Score: 85%
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/30/09
Relevance Score: 84%
A purpuric rash
Australian Family Physician, 11/09/09
Relevance Score: 84%
The effect of clinical severity and eyelid rash on ocular involvement in primary varicella infection
European Journal of Ophthalmology, 11/05/09
Relevance Score: 84%
Today in Patient Counseling...keeping you current
Receive free subspecialty "5-minute updates" via email
Leber congenital amaurosis: Clinical correlations with genotypes, gene therapy trials update, and future directions
Journal of American Association for Pediatric Ophthalmology and Strabismus , 12/17/09
Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: Opinions of Saskatchewan family physicians
Canadian Family Physician, 12/17/09
Pharmacist and physician collaborative prescribing: For medication renewals within a primary health centre
Canadian Family Physician, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor